
Microbot Medical MBOT
$ 1.93
4.32%
Quarterly report 2026-Q1
added 05-13-2026
Microbot Medical Operating Cash Flow 2011-2026 | MBOT
Annual Operating Cash Flow Microbot Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 M | -8.83 M | -8.53 M | -11.5 M | -9.35 M | -7.25 M | -6.45 M | -5.31 M | -4.86 M | -786 K | -765 K | -27.4 M | -23.3 M | -19.9 M | -22.1 M | -24.5 M | -24.7 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -765 K | -27.4 M | -12.9 M |
Quarterly Operating Cash Flow Microbot Medical
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.05 M | - | - | -2.87 M | - | - | - | -2.42 M | - | - | - | -3.2 M | - | -9.09 M | -6.13 M | -3.01 M | - | -6.47 M | -4.29 M | -1.99 M | - | -5.38 M | -3.69 M | -2.35 M | - | -4.53 M | -3.2 M | -2.72 M | - | -3.88 M | -1.35 M | -1.19 M | - | -1.35 M | -1.43 M | -767 K | - | -421 K | -53 K | -293 K | - | - | - | -8.91 M | - | -21 M | -14.3 M | -6.51 M | - | -16.4 M | -10.4 M | -6.65 M | - | -14.9 M | -10.7 M | -5.63 M | - | -16.8 M | -13.1 M | -7.42 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -53 K | -21 M | -6.05 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
796 M | $ 60.58 | 0.33 % | $ 12.1 B | ||
|
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
80.9 M | $ 115.46 | 1.14 % | $ 3.7 B | ||
|
ICU Medical
ICUI
|
180 M | $ 120.37 | -2.13 % | $ 2.97 B | ||
|
Repro Med Systems
KRMD
|
462 K | $ 3.87 | -2.76 % | $ 179 M | ||
|
Intuitive Surgical
ISRG
|
3.03 B | $ 421.73 | -1.48 % | $ 151 B | ||
|
LeMaitre Vascular
LMAT
|
81.3 M | $ 97.52 | -1.99 % | $ 2.21 B | ||
|
Alcon
ALC
|
1.34 B | $ 63.93 | -0.14 % | $ 40.4 B | ||
|
Masimo Corporation
MASI
|
196 M | $ 178.4 | 0.03 % | $ 9.51 B | ||
|
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
276 M | $ 23.69 | -0.67 % | $ 3.98 B | ||
|
electroCore
ECOR
|
-8.19 M | $ 6.29 | -2.18 % | $ 53.4 K | ||
|
Haemonetics Corporation
HAE
|
182 M | $ 56.6 | -0.86 % | $ 2.85 B | ||
|
STAAR Surgical Company
STAA
|
-34.2 M | $ 32.27 | 0.81 % | $ 1.6 B | ||
|
STERIS plc
STE
|
1.15 B | $ 214.08 | -0.88 % | $ 21.1 B | ||
|
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
-57.8 M | $ 141.43 | -0.52 % | $ 6.85 B | ||
|
InfuSystem Holdings
INFU
|
24.4 M | $ 8.57 | -0.46 % | $ 177 M | ||
|
Milestone Scientific
MLSS
|
-2.92 M | $ 0.33 | -1.64 % | $ 27.1 M | ||
|
Merit Medical Systems
MMSI
|
297 M | $ 62.4 | -0.26 % | $ 3.69 B | ||
|
Utah Medical Products
UTMD
|
14.7 M | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
755 M | $ 301.39 | 0.4 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
-54.1 M | $ 24.12 | -11.01 % | $ 1.63 B | ||
|
DENTSPLY SIRONA
XRAY
|
235 M | $ 10.04 | -3.6 % | $ 2 B | ||
|
Retractable Technologies
RVP
|
-7.06 M | $ 0.69 | - | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
-1.68 M | $ 59.95 | 2.22 % | $ 197 M | ||
|
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
20.1 M | $ 20.55 | -2.42 % | $ 981 M | ||
|
Stereotaxis
STXS
|
-13.7 M | $ 1.87 | -3.86 % | $ 170 M | ||
|
Baxter International
BAX
|
845 M | $ 17.32 | -2.64 % | $ 8.89 B | ||
|
ResMed
RMD
|
351 M | $ 202.53 | -0.01 % | $ 29.6 B | ||
|
AtriCure
ATRC
|
57.3 M | $ 28.37 | 0.79 % | $ 1.35 B | ||
|
Harvard Bioscience
HBIO
|
6.73 M | $ 5.36 | -2.9 % | $ 238 M | ||
|
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-10.1 M | $ 10.88 | -1.36 % | $ 444 M | ||
|
Becton, Dickinson and Company
BDX
|
3.33 B | $ 142.79 | -1.2 % | $ 41.1 B | ||
|
Nephros
NEPH
|
1.64 M | $ 3.16 | -5.39 % | $ 33.5 M | ||
|
OraSure Technologies
OSUR
|
-49 M | $ 3.08 | 4.24 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
117 M | $ 105.36 | 1.91 % | $ 5.92 M |